medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2022, Number 2

<< Back Next >>

Salud Mental 2022; 45 (2)

Transition from first illegal drug use to first injection among people who inject drugs in Northern Mexico: A retrospective survival analysis

Ospina-Escobar A, Magis-Rodríguez C

Language: English
References: 46
Page: 71-80
PDF size: 246.31 Kb.


ABSTRACT

Introduction. There is little information in Mexico about the transition to injecting drugs among drug users in cities other than Tijuana. Objective. We compare characteristics of the onset of drug use and first injection among people who inject drugs (PWID) from Ciudad Juárez and Hermosillo, two cities of Northern Mexico and identify factors associated with faster rates of transition from first drug use to the first injection. Method. 841 PWID were interviewed in 2012 in Ciudad Juárez (n = 445) and Hermosillo (n = 396). Using lifetables, we describe timing at the onset of drug use and first injection. Cox regression analysis was used to determine factors associated with the transition hazard to first injection. Results. Median age at onset of drug use was 15.5 years old (standard deviation [SD] = 5.73). The median age at first injection was 21.30 (SD = 7.22). The median duration-time between first drug use and transition to injection was 4.8 years (SD = 5.6). Controlling for sociodemographics, factors that increase the hazard of transitioning to injection are age at onset of drug use (adjusted-hazard-rate [AHR] = 1.04, 95% confidence-interval CI [1.03, 1.05], p ‹ .01) having used cocaine, heroin, or methamphetamine at the onset of drug use (AHR = 1.14, 95% CI [1.03, 1.27], p = .01), and having received assistance at first injection (AHR = 1.25, 95% CI [1.17, 1.33], p ‹ .01). Discussion and conclusion. Results show the need to enhance harm reduction programs among non-injecting drug users so as to prevent the spread of injecting drugs in Mexico.


REFERENCES

  1. Abelson, J., Treloar, C., Crawford, J., Kippax, S., Van Beek, I., & Howard, J. (2006)Some characteristics of early onset injection drug users prior to and at thetime of their first injection. Addiction,101(4), 548-555. doi: 10.1111/j.1360-0443.2006.01379.x

  2. Ambekar, A., Mishra, A., Parmar, A., Kumar, R., Kumar, M., Rao, R., & Agrawal,A. (2019) Are non-injecting opioid users at risk of transition to injecting druguse? A multi-site study from India. Asian Journal of Psychiatry, 42, 79-84. doi:10.1016/j.ajp.2019.03.017

  3. Arreola, S., Bluthenthal, R. N., Wenger, L., Chu, D., Thing, J., & Kral, A. H. (2014).Characteristics of people who initiate injection drug use later in life. DrugAlcohol Depend, 138, 244-250. doi: 10.1016/j.drugalcdep.2014.02.026

  4. Astorga, L. (2016). El siglo de las drogas. Del porfiriato al nuevo milenio. Ciudadde Mexico: Debolsillo.

  5. Baluku, M., Wamala, T., & Muhangi, D. (2019). HIV- and hepatitis C-related riskbehaviors among people who inject drugs in Uganda: implications for policyand programming. Harm Reduction Journal, 16(1), 56. doi: 10.1186/s12954-019-0324-4

  6. Bautista, S., Colchero, A., Sosa, S., & Conde, C. (2012). Diagnóstico situacional,mapeo de sitios de encuentro y evaluación de impacto de las estrategias deprevención de VIH/SIDA en México. Informe sobre la encuesta en sitios deencuentro de UDI. México: Fundación Mexicana para la Salud (Funsalud),Instituto Nacional de Salud Pública (INSP).

  7. Ben Hamida, A., Rafful, C., Jain, S., Sun, S., Gonzalez-Zuniga, P., Rangel, G, …Werb, D. (2018). Non-injection Drug Use and Injection Initiation Assistanceamong People Who Inject Drugs in Tijuana, Mexico. Journal of Urban Health,95(1), 83-90. doi: 10.1007/s11524-017-0188-4

  8. Bloom, B. E., Jain, S., Sun, X., Garfein, R. S., Strathdee, S. A., Milloy, M.-J., … Rafful,C. (2021) Self-perception of assisting with future injection drug initiation: Theinfluence of relationships in the process of drug injecting initiation. Drug andAlcohol Review, 40(1), 109-117. doi: 10.1111/dar.13145

  9. Bluthenthal, R. N., Wenger, L., Chu, D., Bourgois, P., & Kral, A. H. (2017). Drug usegenerations and patterns of injection drug use: Birth cohort differences amongpeople who inject drugs in Los Angeles and San Francisco, California. Drugand Alcohol Dependence, 175, 210-218. doi: 10.1016/j.drugalcdep.2017.04.001

  10. Bourgois, P. (2003). Crack and the Political Economy of Social Suffering. AddictionResearch & Theory, 11(1), 31-37. doi: 10.1080/1606635021000021322

  11. Brecht, M.-L., Huang, D., Evans, E., & Hser, Y-I. (2008). Polydrug use andimplications for longitudinal research: Ten-year trajectories for heroin, cocaine,and methamphetamine users. Drug and Alcohol Dependence, 96(3), 193-201.doi: 10.1016/j.drugalcdep.2008.01.021

  12. Centro Nacional para la Prevención y Control del VIH y el sida (CENSIDA). (2010).Estimation of population size. Men who have sex with men and People who injectdrugs in priority cities for project “Global Fund to Fight HIV, Tuberculosis, andMalaria Round 9”. Mexico City: Secretary of Health.

  13. Centros de Integración Juvenil [CIJ], & Sistema de Información Epidemiológica delConsumo de Drogas [SIECD]. (2021). Droga de mayor impacto reportada porusuarios de drogas ilícitas solicitantes de tratamiento en Centros de IntegraciónJuvenil del 2° semestre de 2004 al 2° semestre de 2020 (Nivel Nacional yEntidades Federativa). Ciudad de México: Centros de Integración Juvenil.

  14. Cleves, M., Gutiérrez, R., Gould, W., & Marchenko, Y. (2010). An introduction tosurvival analysis using stata. Third Edition. Texas: Stata Press Publication.

  15. Crofts, N., Louie, R., Rosenthal, D., & Jolley, D. (1996). The first hit: circumstancessurrounding initiation into injecting. Addiction, 91(8), 1187-1196. doi:10.1046/j.1360-0443.1996.918118710.x

  16. Doherty, M. C., Garfein, R. S., Monterroso, E., Brown, D., & Vlahov, D. (2000).Correlates of HIV infection among young adult short-term injection drug users.AIDS, 14(6), 717-726. doi: 10.1097/00002030-200004140-00011

  17. Fleiz-Bautista, C., Domínguez-García, M., Villatoro-Velázquez, J. A., Vázquez-Quiroz, F., Zafra-Mora, E., Sánchez-Ramos R., … Medina-Mora, M. E. (2019).Cuqueando la Chiva: Contextos del consumo de heroína en la frontera norte deMéxico. Ciudad de México: INPRFM.

  18. Fuller, C. M., Vlahov, D., Ompad, D. C., Shah, N., Arria, A., & Strathdee, S. A.(2002). High-risk behaviors associated with transition from illicit non-injectionto injection drug use among adolescent and young adult drug users: a casecontrolstudy. Drug and Alcohol Dependence, 66(2), 189-198. doi: 10.1016/s0376-8716(01)00200-9

  19. Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., & Nelson, K. E. (1996). Viralinfections in short-term injection drug users: the prevalence of the hepatitis C,hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. AmJ Public Health, 86(5), 655-661. doi: 10.2105/ajph.86.5.655

  20. Horyniak, D., Stoové, M., Degenhardt, L., Aitken, C., Kerr, T., & Dietze, P. (2015).How do drug market changes affect characteristics of injecting initiation andsubsequent patterns of drug use? Findings from a cohort of regular heroin andmethamphetamine injectors in Melbourne, Australia. Int JDrug Policy, 26(1),43-50. doi: 10.1016/j.drugpo.2014.09.002

  21. Hser, Y. (2007). Predicting long-term stable recovery from heroin addiction: Findingsfrom a 33-year follow-up study. Journal of Addictive Diseases, 26(1), 51-60.doi: 10.1300/J069v26n01_07

  22. Koozegar, M., Shahesmaeili, A., & Noroozi, M. (2018). Transition from First DrugUse to Regular Injection among People Who Inject Drugs in Iran. AddictHealth, 10(1), 32-40. doi: 10.22122/ahj.v10i1.458

  23. Ly, K. N., Xing, J., Klevens, R. M., Jiles, R. B.,Ward, J. W., & Holmberg, S. D. (2012).The increasing burden of mortality from viral hepatitis in the United Statesbetween 1999 and 2007. Ann Intern Med, 156(4), 271-278. doi: 10.7326/0003-4819-156-4-201202210-00004

  24. Medel, M., Lu, Y., & Chow, E. (2015). Mexico’s drug networks: Modeling thesmuggling routes towards the United States. Applied Geography, 60, 240-247.doi: 10.1016/j.apgeog.2014.10.018

  25. Meyers, S. A., Rafful, C., Mittal, M. L., Smith, L. R., Tirado-Muñoz, J., Jain, S.,… Scheim, A.I. (2021). Examining the gender composition of drug injectinginitiation events: A mixed methods investigation of three North Americancontexts. International Journal of Drug Policy, 90, 103056. doi: 10.1016/j.drugpo.2020.103056

  26. Mittal, M. L., Guise, A., Rafful, C., Gonzalez-Zuñiga, P., Davidson, P., Vashishtha,D., … Werb, D. (2019). “Another Person Was Going to Do It”: TheProvision of Injection Drug Use Initiation Assistance in a High-Risk U.S.-Mexico Border Region. Substance Use & Misuse, 54(14), 2338-2350. doi:10.1080/10826084.2019.1648514

  27. Morris, M., Brouwer, K., Lozada, R., Gallardo, M., Vera, A., & Strathdee, S.(2012). “Injection First”: A Unique Group of Injection Drug Users in Tijuana,Mexico. American Journal on Addictions, 21(1), 23-30. doi: 10.1111/j.1521-0391.2011.00194.x

  28. Neaigus, A., Miller, M., Friedman, S. R., Hagen, D. L., Sifaneck, S. J., Ildefonso, G.,& Des Jarlais, D. C. (2001). Potential risk factors for the transition to injectingamong non-injecting heroin users: a comparison of former injectors and neverinjectors. Addiction, 96(6), 847-860. doi: 10.1046/j.1360-0443.2001.9668476.x

  29. Oliveira, M. L., Hacker, M. A., Nóbrega, S. A., Telles, P. R., Rodrigues, K. M.,Yoshida, C. F. & Bastos, F. I. (2006). “The first shot”: The context of firstinjection of illicit drugs, ongoing injecting practices, and hepatitis C infectionin Rio de Janeiro, Brazil. Cad Saude Publica, 22(4), 861-870. doi: 10.1590/s0102-311x2006000400024

  30. Ospina-Escobar, A. (2016a). Discutiendo la hipótesis de la “puerta de entrada” delinicio del uso de drogas ilegales. Revista Internacional de Investigación enAdicciones, 2(2), 3-12. doi: 10.28931/riiad.2016.2.02

  31. Ospina-Escobar, A. (2016b). Itinerarios de adversidad. Biografías de uso de drogas,estilos de vida y ambientes de riesgo al VIH en varones inyectores de Tijuana,Cd. Juárez y Hermosillo, México. Tesis de doctorado en Estudios de Población.Ciudad de México: El Colegio de México.

  32. Ospina-Escobar, A., Magis-Rodríguez, C., Juárez, F., Werb, D., Bautista Arredondo,S., Díaz-Carreón, R., ... Strathdee, S. (2018). Comparing risk environmentsfor HIV among people who inject drugs from three cities in Northern Mexico.Harm Reduction Journal, 15, 27. doi: 10.1186/s12954-018-0225-y

  33. Ospina-Escobar, A. (2019). Changes in the Dynamics ofDrug Dealing and Use.AGenerational Analysis for Hermosillo, Sonora. International Journal ofBorders, Territories and Regions, 31(9), 1-25. doi: 10.33679/rfn.v1i1.2035

  34. Pan American Health Organization [PAHO]. (2008). Encuestas de Comportamientoen Consumidores de Drogas con Alto Riesgo (CODAR). Herramientas básicaspara vigilancia de segunda generación de la transmisión de VIH y otras ITSen CODAR. Retrieved from https://www3.paho.org/hq/index.php?option=com_content&view=article&id=853:2009-encuestas-comportamientoconsumidores-drogas-alto-riesgo-codar&Itemid=820&lang=en

  35. Pressat, R. (2000). El análisis demográfico. Métodos, resultados, aplicaciones [Thedemographic analysisl. Methods, results and applications]. Mexico: Fondo deCultura Económica.

  36. Rafful, C., Jain, S., Sun, X., Strathdee, S. A., Garfein, R. S., Cuevas-Mota, J., …Werb, D. (2018). Identification of a Syndemic of Blood-Borne DiseaseTransmission and Injection Drug Use Initiation at the US-Mexico Border.Journal of Acquired Immune Deficiency Syndromes, 79(5), 559-565. doi:10.1097/QAI.0000000000001858

  37. Robertson, A., Lozada, R., Pollini, R., Rangel, G., & Ojeda, V. (2012) Correlates andcontexts of US Injection Drug Initiation among undocumented mexican migrantwho were deported from de United States. Aids Behavior, 16(6), 1670-1680.doi: 10.1007/s10461-011-0111-z

  38. Roy, E., Haley, N., Leclerc, P., Cédras, L., Blais, L., & Boivin, J. F. (2003). Druginjection among street youths in Montreal: predictors of initiation. Journal ofUrban Health, 80(1), 92-105. doi: 10.1093/jurban/jtg092

  39. Secretaría de Salud, Subsecretaría de Prevención y Promoción de la Salud & DirecciónGeneral de Epidemiología. (2020). Sistema de Vigilancia Epidemiológica de lasAdicciones (SISVEA) Informe 2017-2018. Ciudad de México. Retrieved fromhttps://epidemiologia.salud.gob.mx/gobmx/salud/documentos/info_sisvea/informes_sisvea_2017-2018.pdf

  40. Valenzuela, E., & Fernández, M. (2011). The Sequence of Drug Use: Testing theGateway Hypothesis in Latin America. The Journal of International Drug,Alcohol and Tobacco Research, 1(1), 1-8.

  41. Vidal-Trecan, G. M., Varescon-Pousson, I., & Boissonnas, A. (2002). Injectionrisk behaviors at the first and at the most recent injections among drugusers. Drug and Alcohol Dependence, 66(2), 107-109. doi: 10.1016/S0376-8716(01)00196-X

  42. Villatoro-Velázquez, J. A., Medina-Mora, M. E., Fleiz-Bautista, C., Téllez-Rojo,M. M., Mendoza-Alvarado, L. R., Romero-Martínez, M., … Alvear Sevilla,C. (2012) National Survey of Alcohol, Tobacco and Drug Use, 2011, DrugsReport. Mexico City: National Institute of Psychiatry Ramón de la FuenteMuñiz; National Institute of Public Health; Secretary of Health.

  43. Villatoro-Velázquez, J. A., Resendiz-Escobar, E., Mujica-Salazar, A., Bretón-Cirett,M., Cañas-Martínez, V., Soto-Hernández, I., … Mendoza-Alvarado, L. (2017).National Survey of Alcohol, Tobbacco and Drug Use, 2016, Drugs Report.Mexico City: National Institute of Psychiatry Ramón de la Fuente Muñiz;National Institute of Public Health; Secretary of Health.

  44. Vlahov, D., Fuller, C. M., Ompad, D. C., Galea, S., & Des Jarlais, D. C. (2004).Updating the infection risk reduction hierarchy: preventing transition intoinjection. Journal of Urban Health, 81(1), 14-19. doi: 10.1093/jurban/jth083

  45. Vorobjov, S., Des Jarlais, D. C., Abel-Ollo, K., Talu, A., Rüütel, K., & Uusküla,A. (2013) Socio-demographic factors, health risks and harms associated withearly initiation of injection among people who inject drugs in Tallinn, Estonia:Evidence from cross-sectional surveys. Int J Drug Policy, 24(2), 150-155. doi:10.1016/j.drugpo.2012.08.003

  46. Werb, D., Bluthenthal, R. N., Kolla, G., Strike, C., Kral, A. H., Uusküla, A., & DesJarlais, D. (2018). Preventing injection drug use initiation: state of the evidenceand opportunities for the future. J Urban Health, 95(1), 91-98. doi: 10.1007/s11524-017-0192-8




2020     |     www.medigraphic.com